Kafukufuku watsopano wowunikiridwa ndi anzawo akutsimikizira kuti HemoScreen imatha kuwunika mwachangu odwala omwe ali ndi leukemia

Kafukufuku akuwonetsa kuti PixCell's HemoScreen™ itha kugwiritsidwa ntchito kuyang'anira zitsanzo zamagazi ndikuwongolera chithandizo cha odwala omwe ali ndi matenda a magazi.
ILIT, York, Israel, Okutobala 13, 2020 /PRNewswire/ - PixCell Medical, woyambitsa njira zodziwira matenda am'mbali mwa bedi, lero alengeza zotsatira za kafukufuku watsopano wofalitsidwa mu International Journal of Laboratory Hematology Zotsatira zake, kafukufukuyu akuwonetsa kuti HemoScreen™ blood analyzer ya kampani ndiyoyenera kuunika ndikuwongolera odwala omwe ali ndi khansa ya m'magazi omwe akulandira chithandizo cha chemotherapy.
Ofufuza ochokera ku North New Zealand Hospital, University of Copenhagen, Bispebjerg ndi Frederiksberg Hospitals ku Copenhagen, ndi University of Southern Denmark anayerekezera HemoScreen™ ndi Sysmex XN-9000 mu 206 zitsanzo mtsempha wachizolowezi ndi 79 cell blood cell (WBC) capillary bedside. zitsanzo , Absolute neutrophil count (ANC), red blood cell (RBC), platelet count (PLT) ndi hemoglobin (HGB).
"Odwala khansa omwe akudwala kwambiri chemotherapy nthawi zambiri amavutika ndi kuponderezedwa kwakukulu kwa mafupa chifukwa cha chithandizo ndipo amafuna kuyang'anitsitsa nthawi zonse magazi athunthu (CBC)," anatero Dr. Avishay Bransky, Mtsogoleri wamkulu wa PixCell Medical."Kafukufukuyu akuwonetsa kuti HemoScreen ikhoza kupereka zotsatira zachangu komanso zodalirika zamatsanzo wamba komanso zitsanzo zamatenda.Kugwiritsiridwa ntchito kofala kwa chipangizochi kungathe kuthetsa maulendo opita kuchipatala osafunikira ndikufupikitsa kwambiri nthawi yofunikira yofunsira-kwa iwo omwe akudwala kale ndi kutopa.Kwa odwala, awa ndi masewera osintha. "
Deta ikuwonetsa kuti HemoScreen imagwiritsa ntchito 40 μl ya magazi a venous kapena capillary komanso kutsika kochepa kwa WBC, ANC, RBC, PLT ndi HGB kuti apereke zotsatira zoyezetsa mwachangu komanso zodalirika zowongolera kuikidwa magazi ndi chithandizo chamankhwala pambuyo pa chemotherapy.Gulu lofufuzalo lidapezanso kuti HemoScreen imakhudzidwa mokwanira ndi ma tag pathological samples ndi ma cell achilendo (kuphatikiza maselo ofiira a nucleated, ma granulocyte osakhwima, ndi maselo akale), ndipo amachepetsa kwambiri nthawi yosinthira zotsatira za mayeso.
HemoScreen™, yopangidwa ndi PixCell Medical, ndiye chowunikira chokhacho cha hematology chovomerezedwa ndi FDA, chopangidwira chisamaliro chapadera (POC), kuphatikiza ma flow cytometry ndi kujambula kwa digito papulatifomu imodzi.Makina osanthula a compact hematology analyzer amatha kumaliza mayeso athunthu a magazi (CBC) m'mphindi 6, ndipo amagwiritsa ntchito zida zotayira zomwe zimadzaziridwatu ndi zopangira zonse zofunika kuti ayese mwachangu, molondola komanso mophweka.
Kafukufukuyu adatsimikiza kuti HemoScreen ndiyoyenera kwambiri kuzipatala zing'onozing'ono zakunja ndipo ingakhale yoyenera kugwiritsidwa ntchito kunyumba.
PixCell Medical imapereka njira yoyamba yodziwira magazi pompopompo.Pogwiritsa ntchito ukadaulo wa kampani wa viscoelastic focusing focus and vision of artificial intelligence machine, PixCell's FDA-approved and CE-approved CE HemoScreen diagnostic platform imachepetsa nthawi yobweretsera zotsatira za matenda kuchokera masiku angapo mpaka mphindi zochepa.Ndi dontho la magazi chabe, PixCell ikhoza kupereka kuwerengera kolondola kwa magawo 20 a chiwerengero cha magazi mkati mwa mphindi zisanu ndi chimodzi, kupulumutsa odwala, madokotala ndi machitidwe a zaumoyo nthawi yambiri ndi ndalama.


Nthawi yotumiza: Jul-15-2021